Technologist II, Maternal Fetal Care Section
Omayma Abdulla Al-Saei is a research specialist in the Translational Medicine division of the Research Department at Sidra Medicine. She graduated with a BSc in Biomedical Sciences from Qatar University in 2013, and MSc in Human Molecular Genetics from Imperial College London in 2015. She has an experience in different biological and molecular analysis techniques as well as in the basics of genetic editing using CRISPR/CAS9 technology. She was also trained and worked on cancer stem cells at Weill Cornell Medicine-Qatar (WCM-Q). She is now involved in several projects that include functional studies and in-depth characterization of syndromes such as autism, metabolic disorders, and childhood diabetes. Currently, she is working on the bioinformatics and genetic analysis of eye disorders within the population of Qatar using data from the Qatar Genome Programme (QGP). Her ultimate goal is to translate data from the state-of-the-art sequencing technologies into customized gene panels of human diseases commonly found in Qatar, which could eventually be useful for the clinical diagnosis as well as prediction of prognosis or outcomes of diseases in the population.